Retour sur lavenir.net
   RECTICEL 13.920 € (+8,75 %)     CMB.TECH 15.960 € (+2,31 %)     ACKERMANS V.HAAREN 275.400 € (+6,74 %)     GIMV 44.450 € (+1,14 %)     DEME GROUP 180.000 € (0,00 %)     COLRUYT 38.840 € (+0,10 %)     XIOR 27.100 € (+0,74 %)     ELIA GROUP 128.800 € (+1,66 %)     AB INBEV 68.240 € (+1,46 %)     D'IETEREN GROUP 175.300 € (+0,75 %)     LOTUS BAKERIES 12 740.000 € (-1,85 %)     ARGENX SE 903.800 € (-0,40 %)     AGEAS 74.450 € (+1,02 %)     MONTEA 65.400 € (-0,76 %)     VASTNED 28.500 € (0,00 %)     TUBIZE-FIN 187.400 € (-1,73 %)     WDP 21.340 € (+0,38 %)     SYENSQO 81.300 € (+2,01 %)     IBA 16.900 € (+2,18 %)     UMICORE 23.820 € (+1,71 %)     SOLVAY 25.740 € (+1,34 %)     ONWARD MEDICAL 2.455 € (+6,28 %)     BIOTALYS 2.500 € (-2,34 %)     BEKAERT 38.400 € (-0,26 %)     CFE 11.500 € (+0,88 %)     VGP 81.600 € (+1,24 %)     DECEUNINCK 2.435 € (-0,61 %)     BANQUP GROUP 2.110 € (+9,04 %)     AEDIFICA 68.200 € (-0,22 %)     SHURGARD 23.300 € (+0,22 %)     BARCO 7.930 € (+1,54 %)     KBC 132.750 € (+0,84 %)     SOFINA 249.400 € (+1,05 %)     AZELIS GROUP 12.310 € (+2,58 %)     UCB 217.500 € (-1,98 %)     KINEPOLIS GROUP 45.950 € (+0,55 %)     OXURION 0.003 € (0,00 %)     WERELDHAVE BELGIUM 51.600 € (-0,39 %)     BPOST 1.316 € (+2,81 %)     FLUXYS BELGIUM D 22.400 € (+0,90 %)     MELEXIS 66.450 € (+0,68 %)     ONTEX GROUP 2.815 € (+0,36 %)     GBL 73.850 € (+0,89 %)     KBC ANCORA 94.400 € (+0,75 %)     ASCENCIO 51.600 € (-0,19 %)     CIE BOIS SAUVAGE 292.000 € (-0,68 %)     EVS 30.550 € (+1,50 %)     CARE PROPERTY INV. 12.180 € (+0,16 %)     TINC 11.240 € (+0,54 %)     ATENOR 1.290 € (0,00 %)     CENERGY 22.860 € (+0,44 %)     HOME INVEST BE. 18.780 € (-0,63 %)     TESSENDERLO 23.450 € (-1,68 %)     BREDERODE 103.600 € (0,00 %)     CAMPINE 201.000 € (+2,81 %)     PROXIMUS 6.290 € (-0,32 %)     VAN DE VELDE 30.500 € (-0,65 %)     IMMOBEL 20.400 € (-2,86 %)     TITAN S.A. 53.950 € (+2,37 %)     JENSEN-GROUP 74.400 € (+0,54 %)  
   MAUNA KEA TECH 0.161 € (+3,21 %)     PLANISWARE 24.700 € (+0,20 %)     ATON 0.017 € (+2,41 %)     EMEIS 12.800 € (+1,11 %)     METAVISIO 0.001 € (0,00 %)     FDJ UNITED 22.360 € (-0,04 %)     HAVAS 18.500 € (0,00 %)     CRCAM NORD CCI 30.405 € (+0,66 %)     TITAN 2.500 € (+5,04 %)     AYVENS 11.010 € (+1,01 %)     CVC CAPITAL 14.820 € (+0,47 %)     EUTELSAT COMMUNIC. 1.887 € (+2,03 %)     WORLDLINE 13.994 € (+1,55 %)     SPIE 43.660 € (+0,83 %)     LEGRAND 141.000 € (+3,37 %)     ABIVAX 98.400 € (-1,55 %)     AVANTIUM 4.990 € (+1,53 %)     HERMES INTL 1 612.500 € (+3,17 %)     SANOFI 77.200 € (-0,10 %)     NEXANS 145.000 € (+1,61 %)     LVMH 457.850 € (+2,34 %)     CREDIT AGRICOLE 18.325 € (+0,38 %)     AIRBUS 203.100 € (-0,15 %)     EUROFINS SCIENT. 72.700 € (-0,41 %)     RANDSTAD NV 40.140 € (+0,90 %)     KERING 255.750 € (+2,08 %)     GENSIGHT BIOLOGICS 0.125 € (-0,79 %)     BNP PARIBAS ACT.A 101.360 € (+0,70 %)     TELEPERFORMANCE 70.800 € (-0,98 %)     PARROT 9.150 € (-0,97 %)     SCHNEIDER ELECTRIC 302.600 € (+1,70 %)     SOCIETE GENERALE 72.150 € (+1,58 %)     ASML HOLDING 1 486.600 € (+0,01 %)     VALLOUREC 17.875 € (+0,25 %)     TME PHARMA 0.136 € (-4,09 %)     MOTA ENGIL 4.892 € (+1,49 %)     ASR NEDERLAND 71.760 € (+1,41 %)     GETLINK SE 18.580 € (+0,16 %)     MAGNUM 17.176 € (-0,84 %)     UNIBAIL-RODAMCO-WE 99.080 € (-0,14 %)     THALES 246.700 € (0,00 %)     STMICROELECTRONICS 43.830 € (+0,56 %)     CROSSJECT 1.660 € (-1,19 %)     B.COM.PORTUGUES 1.120 € (+1,17 %)     HEIJMANS KON 89.850 € (+1,99 %)     J.MARTINS,SGPS 18.050 € (+0,28 %)     LHYFE 2.155 € (+0,70 %)     EURONEXT 165.200 € (-0,06 %)     AHOLD DEL 30.500 € (-0,20 %)     BIOPHYTIS 0.060 € (-6,98 %)     MICHELIN 34.720 € (+1,11 %)     RENAULT 29.320 € (+3,24 %)     CRCAM BRIE PIC2CCI 36.400 € (+0,28 %)     RELX 30.980 € (-0,83 %)     DASSAULT SYSTEMES 23.050 € (-0,09 %)     DANONE 64.240 € (-0,71 %)     ARCELORMITTAL SA 64.520 € (+0,97 %)     EIFFAGE 109.150 € (+0,32 %)     ENGIE 24.350 € (+1,04 %)     ADP 110.200 € (-1,17 %)  
News Réglementées
28/08/2026 06:40

Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

EQS-News: Fosun / Key word(s): Annual Results/Sales Result
Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

28.08.2026 / 06:40 CET/CEST
The issuer is solely responsible for the content of this announcement.


HONG KONG, Aug. 28, 2026 /PRNewswire/ -- On 27 August 2026, Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), announced its interim results for the six months ended 30 June 2026 (the "Reporting Period").

In the first half of 2026, Fosun continued to advance its business streamlining and core business-focused strategy. Powered by the twin engines of innovation and globalization, the operational quality of its core industries, including pharmaceuticals and healthcare, insurance and finance, and cultural tourism and consumer businesses, steadily improved and gained collective momentum, driving a notable increase in profitability.

During the Reporting Period, the Group's total revenue reached RMB86.96 billion, remaining broadly stable despite the continued divestment of non-strategic and non-core assets; industrial operation profit reached RMB3.69 billion, representing a year-on-year increase of 17%; and profit attributable to owners of the parent reached RMB1.72 billion, representing a significant year-on-year increase of 160.3%.

During the Reporting Period, Fosun's asset base remained solid, with its subsidiaries Fosun Pharma, Yuyuan, Fosun Insurance Portugal (Fidelidade), and Fosun's Tourism segment generating a total revenue of RMB63.88 billion, accounting for 73.5% of the Group's total revenue.

Guo Guangchang, Chairman of Fosun International, said: "Over the past few years, Fosun has steadfastly advanced its business streamlining and core business-focused strategy, and completed a systematic realignment of 'repairing the roof on a sunny day'. The strong earnings recovery we delivered in the first half of this year validates our strategic direction and sustained focus. Fosun has now returned to a growth trajectory and is well-positioned to accelerate its growth going forward."

Supported by its business presence and profound operations in more than 40 countries and regions worldwide, Fosun comprehensively advanced its strategy of "Combining Global Resources with China's Capabilities", deeply integrating China's manufacturing capabilities, service capabilities, and innovation dividends with the global market. In the first half of 2026, overseas revenue reached RMB49.16 billion, representing a year-on-year increase of 5.3%. Its share of total revenue rose by 3 percentage points to 56.5%, underscoring the success of its globalization strategy.

In the first half of 2026, Fosun remained committed to innovation-driven development, fully embraced AI applications, accelerated the conversion of its technology innovations into tangible value, and continued to enhance operational efficiency. During the Reporting Period, Fosun's investment in technology innovation reached RMB4.2 billion, representing a year-on-year increase of 16.7%. Its global innovation system integrating "independent R&D + investment incubation + ecosystem collaboration" continued to gain momentum, fostering a series of globally competitive innovations.

Meanwhile, Fosun adhered to proactive and prudent liquidity and debt management, maintaining sufficient liquidity buffer. During the Reporting Period, the Group generated proceeds equivalent to more than RMB12.0 billion from the divestment of non-strategic and non-core assets. As at 30 June 2026, cash, bank balances and term deposits amounted to RMB61.214 billion, an increase compared to the end of 2025; the total debt to total capital ratio was 55.7%, a further decrease compared to the end of 2025. A healthy debt ratio and ample cash reserves strengthen the Group's risk resilience while also enhancing its capacity to seize investment opportunities.

During the Reporting Period, Fosun continued to gain international recognition for its environmental, social and governance (ESG) performance. Its MSCI ESG rating was upgraded to the highest rating of AAA. It was once again included in S&P Global's Sustainability Yearbook 2026 and ranked among the top 1% in the Sustainability Yearbook (China Edition) 2026. In addition, its FTSE Russell ESG score remained above the global industry and Chinese corporate averages. It was selected as a constituent of the FTSE4Good Index Series for the fifth consecutive year.

Looking ahead, Guo Guangchang said: "The earnings recovery we delivered in the first half of the year was no coincidence. It was the result of Fosun's long-term commitment and sustained focus on its core businesses. Going forward, we will continue to advance innovation-driven and global development in industries where we have established competitive advantages. With a clear path ahead, we are confident that we can steadily restore annual profit to the RMB10 billion level."

Cision View original content:https://www.prnewswire.co.uk/news-releases/fosun-international-reports-1h2026-results-total-revenue-rmb86-96-billion-net-profit-rmb1-72-billion-302862531.html

rt.gif?NewsItemId=EN35844&Transmission_Id=202608280035PR_NEWS_EURO_ND__EN35844&DateId=20260828


28.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2390084  28.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière